Summary
Overview
Work History
Education
Skills
Affiliations
Lecturing
<Enter your own>
Timeline
Generic

Maria Assunta Veneziano

Paris

Summary

15 years of experience in health care and Health Technology Assessment (HTA), with expertise in pharmaceutical and medical device industries. Academic background from the HTA center of Catholic University of the Sacred Heart (UCSC). Skilled in market access in key therapeutic areas such as Primary care (Diabetes, cardiovascular) and Hospital & Specialty Care (Acute care & Infectious diseases). 7 years of people management experience with a global perspective from assignments in diabetes therapeutic area. Strong project management skills and a robust network in public health, HTA, and academic fields. Track record of over 37 scientific publications and more than 60 abstract presentations demonstrating strong presentation and communication abilities. PhD in Health care management and Public health from Università Cattolica del Sacro Cuore and an international Master of Science in Health economics from the University of York.

Overview

16
16
years of professional experience

Work History

Value Market Access Director – Vaccines, Infectious and rare disease, Specialty, Pipeline

MSD Italy
09.2022 - Current
  • People management of a team of 4 (1 jr Specialist, 1 specialist, 1 senior specialist, 1 Associate director)
  • Responsible for: Development of oversight of Health Economics and Outcomes Research (HEOR) strategy to support the value proposition all MSD products
  • Plan and ensure execution by the team of HEOR projects and research (economic models, real world evidence, database research) development, P&R value dossier in alignment with global and national access strategy
  • Defining HTA and HEOR evidence generation plan in alignment with MSD priorities and products lifecycle
  • Provide inputs to global team for clinical research programs to be aligned with regulatory, HTA and P&R criteria and guidelines
  • Networking with key decision makers and HTA, HEOR experts both at national and EU level
  • Responsible for Value Market access and Health economics team on the supervision and coordination of the following key activities: Market access and pricing strategy for P&R negotiation, HEOR evidence generation planning with global team, Value proposition co-creation with global team and customization to national and subnational context, Market access and HTA projects with academia and external vendors, HTA and health economics, Value based health care, Networking both at national and international level (internal and external SHs)
  • Responsible at MSD Italy and EU MSD for working group on EU HTA regulation and focal point for both internal and external SHs.
  • Involved in global project as advisor for pilot activities mainly for rare disease and chronic care

Value Market Access Lead - Associate Director Specialty, Infectious disease and Pipeline

MSD Italy
10.2018 - 08.2022
  • People management of Inf Disease Value market access team of 2 (2 Specialists currently) and up to last year of a team of 3 people (2 specialists+ 1 intern)
  • Lead and coach Value market access team to support local business in the following main activities: National and regional market access strategies, HTA and health economics activities and projects with both internal and external SHs, developing HTA and RW evidence generation and publication plan to accelerate access strategy execution plan, supervision of value and economic tools (Budget impact and economic models, value tools, Economic models, reports) to be used and deployed by regional access team, training activities for regional access team on value tools and evidence dissemination
  • 2 Global Market access project lead assignment that required the coordination of the whole cross functional team and also the coordination with external SHs
  • Global project was focused on defining HC system archetype across EU and non-EU key countries in Diabetes TA
  • Coordination and execution cross functional and country plan on Diabetes value-based health care. This project was selected as first best practice at global level and replicated by other EU countries
  • Local market access strategy plan development and execution in alignment with both global and cross functional teams to unlock access and support MSD value proposition and HTA development
  • Access strategy definition and negotiation strategy for P&R dossier and negotiation in synergy with P&R team
  • Support P&R team for P&R dossier development in alignment with access strategy and economic chapter development
  • HTA&Public affairs Projects, plans and partnerships with all key SHs (Universities, Public heath institutions, Scientific societies, Patients associations)
  • Development and supervision of dissemination plan of key projects outputs’ with both national and regional SHs
  • Monitoring and analyze external environment and trends through external network to proactively collect policy insights order to continuously shape the brand MSD value proposition and anticipate opportunities and mitigate potential risks and guarantee a continuous exchange with both national and global MSD teams
  • Support of Regional Access team by coordinating the development of regional value tools and regional dossier to support regional and local SHs engagement

Value Access - HTA&OR Manager MSc, PhD

MSD Italy
02.2016 - 09.2018
  • HTA, Value and Market access projects with KOL and main national and international institutions, Value tools and dossier development for regional access team to highlight MSD products' value in order to support SHs engagement regional/local Market access activities
  • Project management & Global Market access assignment on Diabetes
  • Cross functional projects and activities across different BUs
  • Strategic support to MSD product strategy development
  • P&R Dossier - economic model development/customization and related economic chapter development, (CEA adaptation, Cost consequence analyses and BIM development);
  • Presentation of HTA projects/activities during internal and external meetings and participation to national and international HTA and public health congresses and meetings

Sr Specialist HTA&OR, MSc, PhD

MSD Italy
05.2014 - 02.2016
  • Development and adaptation of pharmacoeconomic evaluations
  • Cost of illness analyses
  • Health Technology Assessment report preparation for HTA submission
  • Systematic reviews and critical appraisal of pharmacoeconomic studies
  • Project management of economic evaluations and HTA projects
  • Oral presentation of HTA projects/activities during internal and external meetings and participation to national and international HTA and public health congresses and meetings.

Health Economics Researcher, MSc, PhD

Università Cattolica del Sacro Cuore, Rome
01.2010 - 04.2014
  • Pharmacoeconomic evaluations, economic modelling development, customization and adaption to Italian reality on several drugs (also biological), vaccines and medical devices in public health
  • Cost of illness analyses
  • Health Technology Assessment report preparation for HTA submission on several drugs (also biological), medical devices and vaccines also in public health.
  • Team coordination and project management of HTA& economic evaluations
  • Systematic reviews and critical appraisal of pharmacoeconomic studies
  • Projects dealing with Health Care Management and Health Economics and Partnerships with Ministry of Health (SIVEAS project)
  • Preparation of scientific peer reviewed articles, HTA report chapters, book chapters in the field of health economics and Health Impact Assessment
  • Lecturing and distance learning courses in the field of HTA and Health economics

Internship/ Summer Placement at the Economic Evaluation and Health Technology Assessment (TEEHTA)

University of York
07.2012 - 09.2012
  • Cost effectiveness and decision uncertainty, in the field of economic evaluation of health care technologies to develop Msc dissertation.

Education

PhD - Health Economics and Public Health

Università Cattolica del Sacro Cuore
03.2013

Msc - Economic Evaluation and Health Care Decision Making

University of York

MSc - Health Economics

University of York
12.2012

Msc - Health care management and health economics

Università Cattolica del Sacro Cuore
10.2009

BSc - Health care management and health economics

Università Cattolica del Sacro Cuore
07.2007

Skills

  • Inspirational Leadership
  • Ability to Work Under Pressure
  • Time Management
  • Problem solving
  • Flexibility
  • Team working
  • Strong collaboration
  • Communication skills
  • Negotiation skills

Affiliations

AGENAS experts’ panel, epidemiology, HC management and organization of HC services, 2015

Lecturing

  • 2014, Master Universitario di II livello in Epidemiologia e Biostatistica, Università Cattolica del Sacro Cuore (UCSC), Rome
  • 2013, Management clinico organizzativo gestionale del Trapianto di Fegato, Università Cattolica del Sacro Cuore (UCSC), Rome

<Enter your own>

  • Date of Birth: 1985-11-29
  • Nationality: Italian

Timeline

Value Market Access Director – Vaccines, Infectious and rare disease, Specialty, Pipeline

MSD Italy
09.2022 - Current

Value Market Access Lead - Associate Director Specialty, Infectious disease and Pipeline

MSD Italy
10.2018 - 08.2022

Value Access - HTA&OR Manager MSc, PhD

MSD Italy
02.2016 - 09.2018

Sr Specialist HTA&OR, MSc, PhD

MSD Italy
05.2014 - 02.2016

Internship/ Summer Placement at the Economic Evaluation and Health Technology Assessment (TEEHTA)

University of York
07.2012 - 09.2012

Health Economics Researcher, MSc, PhD

Università Cattolica del Sacro Cuore, Rome
01.2010 - 04.2014

Msc - Economic Evaluation and Health Care Decision Making

University of York

MSc - Health Economics

University of York

Msc - Health care management and health economics

Università Cattolica del Sacro Cuore

BSc - Health care management and health economics

Università Cattolica del Sacro Cuore

PhD - Health Economics and Public Health

Università Cattolica del Sacro Cuore
Maria Assunta Veneziano